文献速递妇科肿瘤

FABP5促进宫颈癌细胞生长、侵袭与转移

[FABP5 promotes cell growth, invasion and metastasis in cervical cancer].
PubMed 文献 · Zhonghua Zhong Liu Za Zhi · 2019-01-01

研究检测FABP5在宫颈癌细胞株、206例Ⅰa2~Ⅱa2期宫颈癌组织与40例正常宫颈组织中的表达,并用慢病毒介导siRNA干扰FABP5后观察Siha细胞增殖、迁移、侵袭及裸鼠移植瘤与肺转移。结果显示FABP5在宫颈癌中高表达,干扰后增殖、克隆形成、侵袭与体内成瘤转移均受抑,MMP-2、MMP-9下调。

要点

  • FABP5在宫颈癌组织中的表达显著高于正常宫颈组织(P<0.05)。
  • 干扰FABP5后Siha细胞克隆形成率与穿膜细胞数明显降低(均P<0.05)。
  • 干扰FABP5后裸鼠移植瘤体积与肺转移灶明显减少(P<0.001),MMP-2、MMP-9下调。

核心结论

  • FABP5可促进宫颈癌细胞的增殖、迁移、侵袭和转移,可能通过调节MMP-2和MMP-9的表达发挥作用。

研究设计与样本

  • 研究检测5种宫颈癌细胞株(C33A、Siha、Caski、HeLa、HCC94)、206例Ⅰa2期~Ⅱa2期宫颈癌组织蜡块与40例正常宫颈组织中FABP5 mRNA和蛋白表达。
  • 构建慢病毒介导siRNA靶向FABP5,用CCK-8、平板克隆形成、划痕与Transwell实验检测Siha细胞增殖、迁移和侵袭。
  • 建立雌性裸鼠皮下移植瘤与肺转移瘤模型,观察移植瘤生长与转移灶数目,并检测移植瘤组织MMP-2、MMP-9表达。

主要发现

  • FABP5 mRNA和蛋白在宫颈癌组织中的表达显著高于正常宫颈组织(P<0.05)。
  • 空白对照组、阴性对照组和Siha-FABP5-RNAi组Siha细胞克隆形成率分别为(84.6±4.5)%、(84.6±5.1)%和(21.2±2.6)%,差异有统计学意义(P<0.05)。
  • 空白对照组、阴性对照组和Siha-FABP5-RNAi组穿膜细胞数分别为(72.8±4.7)个/高倍视野、(72.6±3.3)个/高倍视野和(21.4±2.3)个/高倍视野,差异有统计学意义(P<0.05)。
  • 空白对照组、阴性对照组和Siha-FABP5-RNAi组裸鼠皮下移植瘤体积分别为(921.4±63.0)mm³、(1021.4±56.0)mm³和(139.6±36.0)mm³,Siha-FABP5-RNAi组成瘤能力明显降低(P<0.001),每侧肺叶转移灶明显减少(P<0.001)。
  • 空白对照组、阴性对照组和Siha-FABP5-RNAi组移植瘤组织MMP-2 mRNA相对表达量分别为1.00±0.10、1.00±0.10和0.34±0.13,MMP-9 mRNA分别为1.00±0.10、1.00±0.10和0.38±0.17,Siha-FABP5-RNAi组均明显降低(均P<0.05),蛋白表达趋势与mRNA一致。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To investigate the functions of FABP5 in the carcinogenesis and development of cervical cancer. Methods: The expression of FABP5 was detected in several cervical cancer cell lines (C33A, Siha, Caski, HeLa and HCC94), 206 cases of cervical cancer tissues with stage Ⅰa2-Ⅱa2 and 40 cases of normal cervical tissues by real-time PCR and Western blotting. Then, the cells were infected with lentivirus-mediated siRNA-targeting FABP5. CCK-8 cell proliferation, colony formation, wound healing and transwell assays were used to investigate the effects of FABP5 on in vitro cell proliferation, migration and invasion. And in vivo xenograft model and lung metastasis model were used to observe the transplanted tumor growth and metastasis in female athymic nude mice. Furthermore, the total protein and RNA were extracted from the primary xenografts to determine the expression levels of FABP5, metalloproteinase-2 and metalloproteinase-9 using Enzyme linked immunosorbent assay (ELISA), real-time PCR and Western blotting. Results: FABP5 expression was found to be significantly unregulated in cervical cancer tissues than that in normal cervical tissues (P<0.05). Compared with the Siha-NC group and uninfected group, the expression of FABP5 mRNA and protein in Siha-FABP5-RNAi group was significantly inhibited along with the decrease of cell proliferation, colony formation, wound healing and invasion ability. The clone formation rates of Siha cells in uninfected group, Siha-NC group and Siha-FABP5-RNAi group were (84.6±4.5)%, (84.6±5.1)% and (21.2±2.6)%, respectively. Moreover, the transwell assay showed that invasive cells in three groups were (72.8±4.7)/HPF, (72.6±3.3)/HPF and (21.4±2.3)/HPF, respectively. All of the difference was statistically significant (P<0.05). Furthermore, FABP5 silencing significantly reduced tumor growth and lung metastases in nude mice in vivo (P<0.001). The subcutaneously xenografted volume in uninfected group, Siha-NC group and Siha-FABP5-RNAi group was (921.4±63.0) mm(3,) (1 021.4±56.0) mm(3) and (139.6±36.0) mm(3,) respectively. The real-time quantitative PCR results showed that the relative expression levels of MMP-2 and MMP-9 mRNA were 1.00±0.10 and 1.00±0.10, 1.00±0.10 and 1.00±0.10 as well as 0.34±0.13 and 0.38±0.17 in xenografted tumor tissues of uninfected group, Siha-NC group and Siha-FABP5-RNAi group, respectively. MMP-2 and MMP-9 was significantly downregulated after FABP5 inhibition(P<0.05). Additionally, the protein expression trend of MMP-2 and MMP-9 in three groups was consistent with the mRNA levels. Conclusion: FABP5 might promote the carcinogenesis and metastasis of cervical cancer via up-regulating MMP-2 and MMP-9. 目的: 探讨脂肪酸结合蛋白5(FABP5)在宫颈癌发生和发展中的作用机制。 方法: 选取人宫颈癌细胞株C33A、Siha、Caski、HeLa和HCC94,206例Ⅰa2期~Ⅱa2期宫颈癌组织蜡块以及40例正常宫颈组织,采用实时荧光定量PCR和Western blot法检测5种宫颈癌细胞和正常宫颈组织中FABP5 mRNA和蛋白的表达。构建慢病毒载体,采用细胞计数盒8法、平板克隆形成实验、划痕实验、Transwell侵袭实验检测干扰FABP5表达对Siha细胞增殖、迁移和侵袭的影响。以酶联免疫吸附法检测干扰FABP5表达后Siha细胞中基质金属蛋白酶2(MMP-2)和MMP-9的表达。建立裸鼠移植瘤和肺转移瘤模型,观察移植瘤生长曲线和转移瘤数目,分别采用实时荧光定量PCR法、Western blot法检测移植瘤组织中MMP-2和MMP-9 mRNA和蛋白的表达情况。 结果: 与正常宫颈组织的细胞比较,FABP5 mRNA和蛋白在宫颈癌细胞中均呈高表达(P<0.05)。体外实验结果显示,与空白对照组和阴性对照组比较,Siha-FABP5-RNAi组Siha细胞中FABP5 mRNA和蛋白的表达明显受到抑制,增殖能力和克隆形成能力明显减弱,损伤修复能力和侵袭能力明显减弱。空白对照组、阴性对照组和Siha-FABP5-RNAi组Siha细胞的克隆形成率分别为(84.6±4.5)%、(84.6±5.1)%和(21.2±2.6)%,差异有统计学意义(P<0.05)。空白对照组、阴性对照组和Siha-FABP5-RNAi组的穿膜细胞数分别为(72.8±4.7)个/高倍视野、(72.6±3.3)个/高倍视野和(21.4±2.3)个/高倍视野,差异有统计学意义(P<0.05)。体内实验结果显示,空白对照组、阴性对照组和Siha-FABP5-RNAi组裸鼠皮下移植瘤体积分别为(921.4±63.0)mm(3)、(1 021.4±56.0)mm(3)和(139.6±36.0)mm(3),与空白对照组和阴性对照组比较,Siha-FABP5-RNAi组的裸鼠成瘤能力明显降低(P<0.001),且每侧肺叶肿瘤转移灶明显减少(P<0.001)。实时荧光定量PCR法检测结果显示,空白对照组、阴性对照组和Siha-FABP5-RNAi组裸鼠移植瘤组织中MMP-2 mRNA的相对表达量分别为1.00±0.10、1.00±0.10和0.34±0.13;MMP-9 mRNA的相对表达量分别为1.00±0.10、1.00±0.10和0.38±0.17。Siha-FABP5-RNAi组MMP-2和MMP-9 mRNA的表达较空白对照组和阴性对照组明显降低(均P<0.05)。MMP-2和MMP-9蛋白的表达与mRNA的表达趋势一致。 结论: FABP5可促进宫颈癌细胞的增殖、迁移、侵袭和转移,可能通过调节MMP-2和MMP-9的表达发挥作用。.

来源:Zhonghua Zhong Liu Za Zhi,查看原文。版权归原作者所有。

引用

  1. Zhan YZ, Liu F, Zhang Y, et al. [FABP5 promotes cell growth, invasion and metastasis in cervical cancer]. Zhonghua Zhong Liu Za Zhi. 2019. PMID: 30917456. doi:10.3760/cma.j.issn.0253-3766.2019.03.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。